Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	427.22	195.81	102.3	164.16	228.06	54.44
Cash & Short-Term Investments	427.22	195.81	102.3	164.16	228.06	54.44
Cash Growth	286.45%	91.40%	-37.68%	-28.02%	318.94%	0.69%
Accounts Receivable	30.24	26.18	21.33	21.14	12.25	2.55
Other Receivables	0.42	-	-	-	-	-
Receivables	30.65	26.18	21.33	21.14	12.25	2.55
Inventory	2.41	2.31	1.97	1.25	1.2	0.95
Prepaid Expenses	12.74	7.79	4.03	4.75	3.39	2.23
Restricted Cash	-	0.15	-	-	-	-
Other Current Assets	-	-	-	-	1.26	-
Total Current Assets	473.01	232.24	129.63	191.3	246.16	60.17
Property, Plant & Equipment	15.74	18.21	17.9	11.82	13.94	16.81
Other Long-Term Assets	1.61	1.61	1.76	1.76	1.76	1.76
Total Assets	490.37	252.06	149.29	204.89	261.86	78.74
Accounts Payable	4	4.39	5.12	4.59	2.71	3.27
Accrued Expenses	30.45	28.67	24.1	20.12	14.31	7.64
Current Portion of Long-Term Debt	-	-	-	-	8.29	-
Current Portion of Leases	1.72	1.59	1.6	1.62	1.36	1.13
Current Unearned Revenue	0.19	0.26	0.58	-	-	-
Total Current Liabilities	36.36	34.9	31.4	26.34	26.66	12.03
Long-Term Debt	67.82	74.93	54.01	51.44	41.24	49.31
Long-Term Leases	5.59	6.88	8.68	5.92	7.55	8.91
Long-Term Unearned Revenue	14	14.14	13.39	13	12	-
Other Long-Term Liabilities	14.58	30.1	6.44	20.19	98.31	12.12
Total Liabilities	138.35	160.93	113.91	116.89	185.77	82.37
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,195	788.7	652.21	633.8	615.34	379.98
Retained Earnings	-842.7	-697.58	-616.84	-545.8	-539.25	-383.62
Total Common Equity	352.02	91.13	35.38	88	76.1	-3.63
Shareholders' Equity	352.02	91.13	35.38	88	76.1	-3.63
Total Liabilities & Equity	490.37	252.06	149.29	204.89	261.86	78.74
Total Debt	75.12	83.39	64.28	58.98	58.44	59.34
Net Cash (Debt)	352.1	112.42	38.02	105.18	169.62	-4.91
Net Cash Growth	1178.86%	195.70%	-63.86%	-37.99%	-	-
Net Cash Per Share	2.56	1.31	0.46	1.28	2.79	-0.11
Filing Date Shares Outstanding	157.22	148.63	77.51	76.75	76.07	52.58
Total Common Shares Outstanding	156.65	114.96	77.2	76.73	76	50.33
Working Capital	436.65	197.34	98.23	164.96	219.5	48.14
Book Value Per Share	2.25	0.79	0.46	1.15	1.00	-0.07
Tangible Book Value	352.02	91.13	35.38	88	76.1	-3.63
Tangible Book Value Per Share	2.25	0.79	0.46	1.15	1.00	-0.07
Machinery	-	16.78	13.75	12.28	11.47	10.64
Construction In Progress	-	0.28	4.07	0.58	0.12	0.24
Leasehold Improvements	-	14.7	9.07	9.07	9.07	9.07

Source: S&P Capital IQ. Standard template. Financial Sources.